Variant report
Variant | esv3471562 |
---|---|
Chromosome Location | chr5:94332599-94334051 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543116240 | chr5:94332659-94332660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs368855634 | chr5:94332680-94332681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565993598 | chr5:94332780-94332781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562793862 | chr5:94332829-94332830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191052389 | chr5:94332883-94332884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183900840 | chr5:94332920-94332921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551253224 | chr5:94332963-94332964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186837170 | chr5:94332988-94332989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140026966 | chr5:94333027-94333028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371330258 | chr5:94333051-94333052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527626495 | chr5:94333088-94333089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548966653 | chr5:94333106-94333107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547281187 | chr5:94333151-94333152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142782965 | chr5:94333179-94333180 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535828379 | chr5:94333182-94333183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546267267 | chr5:94333202-94333203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs151044984 | chr5:94333215-94333216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62364693 | chr5:94333216-94333217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558410810 | chr5:94333231-94333232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs578213164 | chr5:94333248-94333249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140949753 | chr5:94333263-94333264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191733919 | chr5:94333300-94333301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73774878 | chr5:94333305-94333306 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs150262858 | chr5:94333337-94333338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571695368 | chr5:94333348-94333349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs146881729 | chr5:94333399-94333400 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140640516 | chr5:94333405-94333406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545097198 | chr5:94333427-94333428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564778324 | chr5:94333436-94333437 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72777368 | chr5:94333437-94333438 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs562946385 | chr5:94333452-94333453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547293426 | chr5:94333474-94333475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567423313 | chr5:94333483-94333484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183127260 | chr5:94333486-94333487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549549195 | chr5:94333520-94333521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs72777369 | chr5:94333537-94333538 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs186938548 | chr5:94333599-94333600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374091565 | chr5:94333620-94333621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs59182861 | chr5:94333654-94333655 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs574032706 | chr5:94333727-94333728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191433872 | chr5:94333760-94333761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542896797 | chr5:94333770-94333771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs571877931 | chr5:94333780-94333781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534341355 | chr5:94333792-94333793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554526291 | chr5:94333812-94333813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576531892 | chr5:94333878-94333879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs60244231 | chr5:94333912-94333913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369892935 | chr5:94333993-94333994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145844867 | chr5:94333995-94333996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12517172 | chr5:94334004-94334005 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:94301200-94337600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr5:94313800-94337000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
3 | chr5:94319800-94346600 | Weak transcription | HUVEC | blood vessel |
4 | chr5:94320400-94348000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr5:94322400-94334200 | Weak transcription | Gastric | stomach |
6 | chr5:94325600-94337600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
7 | chr5:94325800-94337400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr5:94326000-94339400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
9 | chr5:94327000-94339200 | Weak transcription | Primary T cells from cord blood | blood |
10 | chr5:94327200-94339000 | Weak transcription | Primary hematopoietic stem cells | blood |
11 | chr5:94330400-94334200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr5:94330400-94336600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
13 | chr5:94331200-94333000 | Weak transcription | Stomach Mucosa | stomach |
14 | chr5:94331400-94334400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr5:94331600-94334200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
16 | chr5:94331600-94334200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr5:94332200-94334200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
18 | chr5:94332200-94334200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
19 | chr5:94333000-94333600 | Enhancers | Stomach Mucosa | stomach |
20 | chr5:94333600-94334000 | Weak transcription | Stomach Mucosa | stomach |
21 | chr5:94334000-94334200 | Enhancers | Stomach Mucosa | stomach |
22 | chr5:94334000-94334600 | Enhancers | HepG2 | liver |